Ben Bergo has more than 20 years of experience in commercial leadership roles in the life sciences sector. Prior to joining Visus as CEO, he served as Executive Vice President of Corporate Development at Planet Innovation, where he led licensing and M&A transactions on behalf of the Planet Group. Additionally, Ben served as cofounder and CEO at Nohla Therapeutics, Inc, a leader in the development of off-the-shelf cell therapies utilizing proprietary expanded cord blood formulations. Prior to this, Ben spun out technologies from Harvard University into a diagnostics venture that was later sold in 2015. Ben worked for five years in venture capital earlier in his career and helped key leadership roles at Vision Systems, contributing to its sale to Danaher in 2006.
Ben holds a Masters in Applied Finance (prize winner) from Macquarie University, a Bachelors of Engineering (Mechanical, 1st Class Honors) from the University of Melbourne, and a Bachelors of Commerce (Economics) from the University of Melbourne.